These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32884056)

  • 1. Untargeted lipidomics reveals progression of early Alzheimer's disease in APP/PS1 transgenic mice.
    Zhang X; Liu W; Zan J; Wu C; Tan W
    Sci Rep; 2020 Sep; 10(1):14509. PubMed ID: 32884056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?
    Ferré-González L; Balaguer Á; Roca M; Ftara A; Lloret A; Cháfer-Pericás C
    Alzheimers Res Ther; 2024 Aug; 16(1):183. PubMed ID: 39143583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampus Proteomics and Brain Lipidomics Reveal Network Dysfunction and Lipid Molecular Abnormalities in APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang X; Liu W; Cao Y; Tan W
    J Proteome Res; 2020 Aug; 19(8):3427-3437. PubMed ID: 32510958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS.
    Zhang AH; Ma ZM; Kong L; Gao HL; Sun H; Wang XQ; Yu JB; Han Y; Yan GL; Wang XJ
    Biomed Chromatogr; 2020 Feb; 34(2):e4724. PubMed ID: 31755117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models.
    Ferré-González L; Lloret A; Cháfer-Pericás C
    Prog Lipid Res; 2023 Apr; 90():101223. PubMed ID: 36871907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry imaging highlights dynamic patterns of lipid co-expression with Aβ plaques in mouse and human brains.
    Huang HX; Inglese P; Tang J; Yagoubi R; Correia GDS; Horneffer-van der Sluis VM; Camuzeaux S; Wu V; Kopanitsa MV; Willumsen N; Jackson JS; Barron AM; Saito T; Saido TC; Gentlemen S; Takats Z; Matthews PM
    J Neurochem; 2024 Jul; 168(7):1193-1214. PubMed ID: 38372586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.
    Gao HL; Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Yan GL; Liu L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():286-295. PubMed ID: 29933222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.
    Byeon SK; Madugundu AK; Jain AP; Bhat FA; Jung JH; Renuse S; Darrow J; Bakker A; Albert M; Moghekar A; Pandey A
    Mol Omics; 2021 Jun; 17(3):454-463. PubMed ID: 34125126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
    Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
    J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.
    Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of
    Liu LW; Yue HY; Zou J; Tang M; Zou FM; Li ZL; Jia QQ; Li YB; Kang J; Zuo LH
    Front Pharmacol; 2022; 13():1076960. PubMed ID: 36618950
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes.
    Liu Y; Thalamuthu A; Mather KA; Crawford J; Ulanova M; Wong MWK; Pickford R; Sachdev PS; Braidy N
    Transl Psychiatry; 2021 Jun; 11(1):344. PubMed ID: 34092785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipidomics study reveals protective effects of Rhodiola crenulata extract on Alzheimer's disease rats.
    Sun W; Liu C; Zhou X; Li X; Chu X; Wang X; Han F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122346. PubMed ID: 32882532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer's Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization-Mass Spectrometry Imaging Techniques.
    Zhang X; Wu C; Tan W
    J Proteome Res; 2021 May; 20(5):2643-2650. PubMed ID: 33780243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodiola crenulata protects against Alzheimer's disease in rats: A brain lipidomics study by Fourier-transform ion cyclotron resonance mass spectrometry coupled with high-performance reversed-phase liquid chromatography and hydrophilic interaction liquid chromatography.
    Sun W; Liu C; Wang Y; Zhou X; Sui W; Zhang Y; Zhang Q; Han J; Li X; Han F
    Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8969. PubMed ID: 33047398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
    Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
    Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.